SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Extra Pale who wrote (181)11/3/2000 12:20:41 PM
From: scaram(o)uche   of 724
 
Extra:

The NBSC concept of IR is to provide the temperature in Edision, 24 hours a day.

The company is priced for failure. I expect, given Eichenbaum as CFO, that they will fail. If it's not parts supply, it will be the euro. If it's not the euro, it will be something else. By the time that Sam can count the next few quarters worth of beans, the backorders will be largely canceled rather than filled.

That is..... while "trickle" should show up on this next quarterly, these guys can't get out of their own way.

But.... it just doesn't make any difference...... (1) "trickle" is going to last for at least the next two years, and (2) Freedman will give up soon, in the face of ongoing performance-related embarrassment. Given DGI, we should do OK in the interim, and.... when Freedman calls it quits, the stock should triple. Would anyone else retain Eichenbaum?

Thanks for your efforts to determine the timing, re. the next release.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News